AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden · Delayed Price · Currency is SEK 1.470
+0.090 (6.52%)
Apr 30, 2026, 12:06 PM CET
AlzeCure Pharma AB Market Cap
AlzeCure Pharma AB has a market cap or net worth of 168.92 million as of April 30, 2026. Its market cap has decreased by -23.17% in one year.
Market Cap
168.92M
Enterprise Value
121.15M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.47
Market Cap Chart
Since November 28, 2018, AlzeCure Pharma AB's market cap has decreased from 415.42M to 168.92M, a decrease of -59.34%. That is a compound annual growth rate of -11.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 158.58M | -31.00% |
| Dec 30, 2025 | 229.83M | 126.34% |
| Dec 30, 2024 | 101.54M | -47.41% |
| Dec 29, 2023 | 193.09M | -24.88% |
| Dec 30, 2022 | 257.04M | 14.39% |
| Dec 30, 2021 | 224.71M | -34.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xintela AB | 228.24M |
| Isofol Medical AB | 225.63M |
| Initiator Pharma | 214.26M |
| Xbrane Biopharma AB | 205.64M |
| Active Biotech AB | 175.30M |
| Diamyd Medical AB | 158.08M |
| Elicera Therapeutics AB | 151.67M |
| Alligator Bioscience AB | 141.32M |